small-cap

Book Profits on This NYSE-Listed Tobacco Play – TPB

Oct 26, 2021 | Team Kalkine
Book Profits on This NYSE-Listed Tobacco Play – TPB

 

Turning Point Brands, Inc.

TPB Details

Turning Point Brands, Inc. (NYSE: TPB) is a producer, marketer, and distributor of branded consumer products, such as alternative smoking accessories and active-ingredient consumables, through its iconic core brands Zig-Zag and Stoker's, as well as its growing brands in the NewGen category. It sells its products in over 210,000 stores across North America and on www.zigzag.com, www.nu-x.com, and www.solacevapor.com. As of October 25, 2021, the company's market capitalization stood at USD 919.90 million.

Latest News:

  • Share Repurchase Program: TPB stated that on October 25, 2021, it increased its share repurchase authorization by USD 30.7 million to USD 50.0 million, with about USD 19.3 million available for repurchases under its prior approval granted on February 25, 2020.
  • FDA Revocation of MDO: The US Food and Drug Administration (FDA) informed TPB on October 11, 2021, that the agency revoked its September 14 Marketing Denial Order (MDO) for some of TPB's vapor products with pending Premarket Tobacco Product Applications (PMTAs) under consideration.

Q3FY21 Results:

  • Minor Improvement in Revenues: The company's net sales increased by 5.50% to USD 109.90 million in Q3FY21 (ended September 30, 2021) compared to USD 104.17 million in Q3FY20.
  • Progress in Bottomline: TPB witnessed an increase in consolidated net income to USD 13.44 million in Q3FY21 vs. USD 9.02 million in Q3FY20.
  • Leveraged Balance Sheet: As of September 30, 2021, the company's cash balance was USD 130.55 million, and total debt amounted to USD 421.04 million.

Key Risks:

  • Dependence on Third-Party Suppliers: TPB's activities heavily rely on a small number of long-term contracts with third-party suppliers and producers. As a result, any interruption in the company's connection with suppliers and producers and failure to renew contracts or the discovery of a new supplier might substantially influence the company's capacity to distribute product quantities, resulting in a drop in financial indicators.

Outlook:

  • Revenue Estimate: TPB estimates FY21 net sales to be in the range of USD 433 – 443 million as of October 26, 2021, assuming double-digit solid sales growth for Zig-Zag products, mid-to-high single-digit sales increase for Stoker's products, and sales decline in NewGen products.
  • Adjusted EBITDA and CAPEX: It also expects adjusted EBITDA to be in the range of USD 104 – 108 million, with a capital expenditure of USD 6 million.
  • Q4FY21 Estimate: TPB anticipates net sales of USD 90 – 103 million in Q4FY21, with growth in the Zig-Zag and Stoker's segments and a double-digit decline in NewGen.

Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

TPB Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

TPB's share price has surged 47.62% in the past twelve months and is currently trading at a mid-band of the 52-week range of USD 31.27 to USD 61.08. The stock is currently trading above its 50 and 100 DMA levels, and its RSI Index is at 61.42. We have valued the stock using the EV/EBITDA-based relative valuation methodology and arrived at a target price of USD 46.32.

Considering the significant uptick in the stock price, highly leveraged balance sheet, and weak Q3FY21 results, we believe the decent business fundamentals are adequately reflected at the current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 48.61 as of October 25, 2021.

 

*All forecasted figures and Industry Information have been taken from REFINITIV.

*The reference data in this report has been partly sourced from REFINITIV.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.


Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.